{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T20:39:04Z","timestamp":1794429544232,"version":"4.9.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12882-019-1241-1","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T14:04:33Z","timestamp":1550153073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Revisiting racial differences in ESRD due to ADPKD in the United States"],"prefix":"10.1186","volume":"20","author":[{"given":"Erin L.","family":"Murphy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina Lehmann","family":"Blount","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline L.","family":"Droher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Liberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deidra C.","family":"Crews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5809-9961","authenticated-orcid":false,"given":"Neera K.","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,14]]},"reference":[{"issue":"3","key":"1241_CR1","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1046\/j.1523-1755.2000.00250.x","volume":"58","author":"M Levy","year":"2000","unstructured":"Levy M, Feingold J. Estimating prevalence in single-gene kidney diseases progressing to renal failure. Kidney Int. 2000;58(3):925\u201343.","journal-title":"Kidney Int"},{"issue":"6","key":"1241_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3949\/ccjm.84a.16107","volume":"84","author":"V Krishnappa","year":"2017","unstructured":"Krishnappa V, Vinod P, Deverakonda D, Raina R. Autosomal dominant polycystic kidney disease and the heart and brain. Cleve Clin J Med. 2017;84(6):471\u201381.","journal-title":"Cleve Clin J Med"},{"issue":"1","key":"1241_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ki.2015.59","volume":"88","author":"AB Chapman","year":"2015","unstructured":"Chapman AB, Devuyst O, Eckardt KU, et al. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2015;88(1):17\u201327.","journal-title":"Kidney Int"},{"issue":"3","key":"1241_CR4","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","volume":"64","author":"AB Chapman","year":"2003","unstructured":"Chapman AB, Guay-Woodford LM, Grantham JJ, et al. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): the consortium for radiologic imaging studies of polycystic kidney disease (CRISP) cohort. Kidney Int. 2003;64(3):1035\u201345.","journal-title":"Kidney Int"},{"issue":"6","key":"1241_CR5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/ki.2011.411","volume":"81","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Perrone RD, et al. Analysis of baseline parameters in the HALT polycystic kidney disease trials. Kidney Int. 2012;81(6):577\u201385.","journal-title":"Kidney Int"},{"issue":"3","key":"1241_CR6","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1681\/ASN.2015010016","volume":"27","author":"E Cornec-Le Gall","year":"2016","unstructured":"Cornec-Le Gall E, Audrezet MP, Rousseau A, et al. The PROPKD score: a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2016;27(3):942\u201351.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1241_CR7","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/ndt\/gfx188","volume":"33","author":"E Cornec-Le Gall","year":"2017","unstructured":"Cornec-Le Gall E, Blais JD, Irazabal MV, et al. Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial. Nephrol Dialy Transplant. 2017;33(4):645\u201352.","journal-title":"Nephrol Dialy Transplant"},{"issue":"1","key":"1241_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1681\/ASN.2013101138","volume":"26","author":"MV Irazabal","year":"2015","unstructured":"Irazabal MV, Rangel LJ, Bergstralh EJ, et al. Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. J Am Soc Nephrol. 2015;26(1):160\u201372.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1241_CR9","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.kint.2017.09.027","volume":"93","author":"ASLSC Yu","year":"2018","unstructured":"Yu ASLSC, Landsittel DP, Harris PC, Torres VE, Mrug M, et al. Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in autosomal dominant polycystic kidney disease. Kidney Int. 2018;93(3):691\u20139.","journal-title":"Kidney Int"},{"issue":"9","key":"1241_CR10","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1681\/ASN.V491670","volume":"4","author":"J Yium","year":"1994","unstructured":"Yium J, Gabow P, Johnson A, Kimberling W, Martinez-Maldonado M. Autosomal dominant polycystic kidney disease in blacks: clinical course and effects of sickle-cell hemoglobin. J Am Soc Nephrol. 1994;4(9):1670\u20134.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1241_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.5414\/CNP57208","volume":"57","author":"KC Abbott","year":"2002","unstructured":"Abbott KC, Agodoa LY. Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol. 2002;57(3):208\u201314.","journal-title":"Clin Nephrol"},{"issue":"1","key":"1241_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0272-6386(00)70298-8","volume":"35","author":"BI Freedman","year":"2000","unstructured":"Freedman BI, Soucie JM, Chapman A, Krishner J, McClellan WM. Racial variation in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2000;35(1):35\u20139.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1241_CR13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1053\/j.ajkd.2014.05.020","volume":"64","author":"S Reule","year":"2014","unstructured":"Reule S, Sexton DJ, Solid CA, Chen SC, Collins AJ, Foley RN. ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010. Am J Kidney Dis. 2014;64(4):592\u20139.","journal-title":"Am J Kidney Dis"},{"key":"1241_CR14","unstructured":"USRDS Renal Data Extraction and Referencing (RenDER) System https:\/\/www.usrds.org\/render ."},{"key":"1241_CR15","unstructured":"Age-adjusted prevalence of CKD Stages 1\u20134 by Race\/Ethnicity 2013\u20132014. Chronic Kidney Disease (CKD) Surveillance Project System. Centers for Disease Control and Prevention https:\/\/nccd.cdc.gov\/CKD\/ ."},{"issue":"11","key":"1241_CR16","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1097\/01.ASN.0000091586.46532.B4","volume":"14","author":"CY Hsu","year":"2003","unstructured":"Hsu CY, Lin F, Vittinghoff E, Shlipak MG. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol. 2003;14(11):2902\u20137.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1241_CR17","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/ndt\/gfq473","volume":"26","author":"K Evans","year":"2011","unstructured":"Evans K, Coresh J, Bash LD, et al. Race differences in access to health care and disparities in incident chronic kidney disease in the US. Nephrol Dial Transplant. 2011;26(3):899\u2013908.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"1241_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1053\/j.ajkd.2012.12.014","volume":"62","author":"JA Green","year":"2013","unstructured":"Green JA, Mor MK, Shields AM, et al. Associations of health literacy with dialysis adherence and health resource utilization in patients receiving maintenance hemodialysis. Am J Kidney Dis. 2013;62(1):73\u201380.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"1241_CR19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1053\/j.ajkd.2003.10.022","volume":"43","author":"JZ Ayanian","year":"2004","unstructured":"Ayanian JZ, Cleary PD, Keogh JH, Noonan SJ, David-Kasdan JA, Epstein AM. Physicians' beliefs about racial differences in referral for renal transplantation. Am J Kidney Dis. 2004;43(2):350\u20137.","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"1241_CR20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.7326\/0003-4819-146-7-200704030-00005","volume":"146","author":"RA Rodriguez","year":"2007","unstructured":"Rodriguez RA, Sen S, Mehta K, Moody-Ayers S, Bacchetti P, O'Hare AM. Geography matters: relationships among urban residential segregation, dialysis facilities, and patient outcomes. Ann Intern Med. 2007;146(7):493\u2013501.","journal-title":"Ann Intern Med"},{"issue":"5","key":"1241_CR21","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.semnephrol.2013.07.008","volume":"33","author":"DC Crews","year":"2013","unstructured":"Crews DC, Pfaff T, Powe NR. Socioeconomic factors and racial disparities in kidney disease outcomes. Semin Nephrol. 2013;33(5):468\u201375.","journal-title":"Semin Nephrol"},{"issue":"4","key":"1241_CR22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1053\/j.ajkd.2007.11.023","volume":"51","author":"MM Ward","year":"2008","unstructured":"Ward MM. Socioeconomic status and the incidence of ESRD. Am J Kidney Dis. 2008;51(4):563\u201372.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"1241_CR23","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1053\/j.ackd.2014.06.005","volume":"21","author":"S Limou","year":"2014","unstructured":"Limou S, Nelson GW, Kopp JB, Winkler CA. APOL1 kidney risk alleles: population genetics and disease associations. Adv Chronic Kidney Dis. 2014;21(5):426\u201333.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"23","key":"1241_CR24","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","volume":"369","author":"AKL Parsa","year":"2014","unstructured":"Parsa AKL, Xie D, Astor BC, Li M, Hsu C, et al. APOL1 risk Varients, race, and progression of chronic kidney disease. N Engl J Med. 2014;369(23):2183\u201396.","journal-title":"N Engl J Med"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1241-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1241-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1241-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T21:53:17Z","timestamp":1662933197000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1241-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,14]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1241"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1241-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,14]]},"assertion":[{"value":"8 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Our data analysis was on aggregate, publicly available population-level data from the USRDS dataset. This type of analysis is exempt from consent as outlined in 45 CFR 46 and in guidance from the Yale Human Research Protection Policy.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"55"}}